FDA Warning Letter — Thomas Jefferson University Institutional Review Board
The FDA took a Warning Letter action against Thomas Jefferson University Institutional Review Board on June 24, 2019 (Philadelphia, PA). The action was issued by CBER and concerns biologics products. This facility has 5 or more recent FDA inspections on record.
Action Details
- Facility
- Thomas Jefferson University Institutional Review Board
- Date
- June 24, 2019
- Fiscal Year
- 2019
- Product Type
- Biologics
- Center
- CBER
- Location
- Philadelphia, PA (United States)